Komori
Makuake (4479) · RiskRestated

Risks Related to the Benefits of Investments Funded by the Proceeds and Changes in Use of Proceeds

First written in FY2019. 3 of 6 entries say "Restated". Latest entry: FY2023.

6entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019 – FY2021MaterialisedFY2022 – FY20222019: 12020: 120202021: 120212022: 220222023: 12023
Same theme, other companies
Risk of Changes in the Use of Proceeds and Failure to Achieve Expected Investment BenefitsA theme 157 companies write about · 157 as a headwind · 0 as a tailwind

57 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 157 companies compared. The sentences above are computed from all 157.
Full recordFilings, disclosures and news, newest first
  1. FY2023RestatedAnnual report

    「The Company expects future investment in system development and capital expenditure to increase compared with previous years and plans to respond by, among other measures, using external contractors.」

    The Company reconfirmed the risks relating to increased system investment, development personnel and costs, suspension or failure of development, failure to achieve the expected benefits, and recognition of impairment losses.
  2. FY2022MaterialisedAnnual report

    「As a result, revenue for the fiscal year was ¥4,206.839 million, down 9.0% year on year; operating loss was ¥324.080 million, compared with operating income of ¥329.101 million in the previous year; ordinary loss was ¥302.562 million, compared with ordinary income of ¥326.089 million; and net loss was ¥1,347.356 million, compared with net income of ¥246.642 million.」

    Against a backdrop of lower usage following reopening and impairment losses, revenue declined and the Company swung to an operating loss, ordinary loss and net loss.
  3. FY2022MaterialisedAnnual report

    「With respect to goodwill and other fixed assets, the Company compared future cash flows with the carrying amounts of the fixed assets using the estimated remaining useful lives of the principal assets as the projection period. As a result, it recognized an impairment loss of ¥1,009.307 million.」

    An impairment loss of ¥1,009.307 million was recognized on system-related and other fixed assets as a result of comparing them with future cash flows.
  4. FY2021RestatedAnnual report

    「The Company expects future investment in system development and capital expenditure to increase compared with previous years and plans to respond by, among other measures, using external contractors.」

    The Company reconfirmed the risks of additional costs or impairment losses arising from increased system investment, development personnel and costs, suspension or failure of development, and failure to achieve the expected benefits.
  5. FY2020RestatedAnnual report

    「With respect to the Company's future investment in system development, if sufficient development personnel cannot be secured, development costs rise significantly, development projects are suspended or fail for various reasons, or the expected benefits are not achieved after development, among other circumstances,」

    The Company reconfirmed the risks relating to the benefits of system development investment, development personnel and costs, changes to plans, and suspension or failure of development projects.
  6. FY2019First statedAnnual report

    「Even if the funds raised are allocated in accordance with the original plan, there is no guarantee that the anticipated investment benefits will be achieved. In addition, the use of the funds raised may change in the future due to changes in the business environment or changes to the Company's business strategy, among other factors.」

    The Company plans to allocate the funds to system development, recruitment, repayment of borrowings, and advertising and promotion.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Makuake's next results are scheduled for 2026-10-27. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risks Related to the Benefits of Investments Funded by the Proceeds and Changes in Use of Proceeds | Makuake,Inc. (4479) | Komori